| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |